Edoardo Melilli

机构：Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Duran i Reynals Hospital, Universitat de Barcelona · ORCID：0000-0001-6965-3745

发表论文 187 篇 · 总被引 3699 次 · h-index 34

代表论文

• A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction (2023 · Kidney International · 被引 47)
• Time trends in preemptive kidney transplantation in Europe: an ERA registry study (2024 · Nephrology Dialysis Transplantation · 被引 19)
• Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis (2024 · Transplantation Reviews · 被引 19)
• Blood Gene Expression Profiling and Donor-derived Cell-free DNA to Noninvasively Diagnose Clinical and Subclinical Kidney Transplant Rejection: A Real-life Appraisal Study (2024 · Transplantation · 被引 11)
• Predictors of Treatment Adherence in Kidney Transplant Patients: A Systematic Review of the Literature (2025 · Journal of Clinical Medicine · 被引 10)
• Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio (2024 · Nefrología (English Edition) · 被引 9)